AliveDx has submitted a 510(k) premarket notification seeking approval from the FDA for its MosaiQ AiPlex CTDplus microarray.

The initiative would seek to automate much of the cloud security program’s approval workflow and shift more control to the private sector. A cornerstone federal program that certifies the ...